RxDoctor Payments Data

Dominique Morgan

Nurse Practitioner · Meridian, IDNPI 1487054730

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $4,250 of the $6,818 with a category attached, or 62.3%. Edwards Lifesciences accounts for 82.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $3,780 and has fallen 61.8% since, to $1,446 in 2025. Among nurse practitioner clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,818in general payments, 2019–2025

Across 81 payments — averaging $84.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$6K
  • Abbott$776
  • Novartis$131
  • AstraZeneca$131
  • Boston Scientific$95
  • Atricure, Inc.$42

What the payments were for

  • Travel & lodging$4,25062%
  • Food & beverage$2,33634%
  • Education$2323%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences65$5,642
Abbott5$776
Novartis4$131
AstraZeneca3$131
Boston Scientific3$95
Atricure, Inc.1$42

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,818 in reported general payments places this provider in the 95th percentile of 570 nurse practitioner providers in Idaho.

See all nurse practitioner providers in Idaho

Medicare billing

Part B allowed, 2024
$13,409
Medicare patients
156
Services billed
260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban73$72,839
FarxigaDapagliflozin Propanediol21$15,871
ClopidogrelClopidogrel Bisulfate110$534
Metoprolol Succinate48$524
Losartan Potassium52$383
Carvedilol57$299
Potassium Chloride26$297
Spironolactone38$256
Atorvastatin Calcium36$236
Pantoprazole Sodium13$208
Nitroglycerin19$198
Furosemide49$160
Torsemide14$99
Amlodipine Besylate37$94
Amoxicillin61$89

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$131$15,87121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 570 nurse practitioner providers in Idaho.

Other nurse practitioner in Meridian

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →